Acta Scientific Microbiology

Editorial Volume 9 Issue 6

Treatment of Neuroendocrine Tumor

Kunal Joon*

Noida International Institute of Medical Sciences, Haryana, India

*Corresponding Author: Kunal Joon, Noida International Institute of Medical Sciences, Haryana, India.

Received: February 26, 2026; Published: May 01, 2026

Abstract

These cancer starts at neuroendocrine cells gene responsible for them p55 and MEN 1, MEN 2 gene, RET gene and most common organs of occurrence is liver, lung, Pancreas, intestine and rectum. These are which releases hormones and cure is repair through stem cell therapy and gene therapy.

Keywords: Gene Therapy; Stem Cell Therapy; DNA Architecture Theory; Gene Editing

References

  1. https://share.google/7diYLVyHUF6fNi7dG
  2. https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net
  3. https://share.google/6iMnb6sJAoVxa8Xsd
  4. Source: National Institutes of Health (.gov) https://share.google/97jrqxsW5r7n9XXbZ
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC10420169/

Citation

Citation: Kunal Joon. “Treatment of Neuroendocrine Tumor". Acta Scientific Microbiology 9.6 (2026): 01-02.

Copyright

Copyright: © 2026 Kunal Joon. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit manuscripts on/before June 18, 2026, for the upcoming issue of 2026.

Contact US